CompletedPhase 4

Effect of Verapamil as an Adjuvant to Local Anaethetics in Supraclav Block for Hand Surgery

Egypt32 participantsStarted 2024-03-01

Plain-language summary

The aim of this study is to evaluate the role of verapamil when added to bupivacaine in ultrasound-giuded supraclavicular Brachial plexus block regarding the duration of action of the block, onset of action and the need of rescue analgesia.

Who can participate

Age range21 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Males and females aged 21-70 years old * Patients with ASA I / II * patients undergoing hand surgeries Exclusion Criteria: * Patients refusal * Skin infection at the injection site. * Contraindications to regional anaesthesia as bleeding disorders * Allergy to bupivacaine or other drugs involved in the study. * Uncooperative patients. * BMI \>35 * Patients taking medications for psychiatric illness

What they're measuring

Primary outcome measure

Timeframe: The duration from giving the block till the need of rescue analgesia in post op 24 hours

Trial details

NCT IDNCT06847620

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-04

View on ClinicalTrials.gov More Hand Surgery trials